1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. ACCELERATE DIAGNOSTICS INC
Accelerate Diagnostics Inc
XNAS: AXDX

Portfolio

Alert

My Notes

Accelerate Diagnostics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Accelerate Diagnostics Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEGATIVE

    Quarterly Revenue Accelerate Diagnostics Inc Dec-2024 Quarterly Revenue is $3 Million which is growth of -7.0% YoY.

  • POSITIVE

    Quarterly Net Profit Accelerate Diagnostics Inc Dec-2024 Quarterly Net Profit is $-10 Million which is growth of 26.2% YoY.

Accelerate Diagnostics Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21
Operating Rev.
2.8332.933.32.92.8333.933.3
Cost Of Rev.
2.42.12.32.22.43.22.11.82.32.22.82.26.7
Gross Profit
0.50.90.70.70.60.10.810.70.81.10.8-3.3
⌄
8.49.59.310.911.414.813.417.114.815.519.116.716.1
Operating Profit
-7.9-8.6-8.6-10.2-10.7-14.7-12.6-16.1-14.2-14.8-18-15.9-19.4
⌄
-4.3-3.4-2.5-2.3-1.9-2-1.7-1-1-0.6-0.7-0.9-3
Profit Before Tax
-9.7-14.6-11.6-14.2-12.41-32.6-16.8-14.9-15.7-17.8-14.2-22.8
Tax
-0.10.60.10.2-0.10
⌄
-9.6-14.6-11.6-14.2-130.9-32.7-16.8-14.8-15.7-17.8-14.2-22.8
Diluted NI Avail to Com Stockholders Ann.
-9.6-14.6-11.6-14.2-130.9-32.7-16.8-14.8-15.7-17.8-14.2-22.8
Basic EPS
-0.4-0.6-0.5-0.7-0.80.1-3-1.7-1.4-1.8-2.3-2.1-3.5
Diluted EPS After ExtraOrdinary
-0.3-0.6-0.5-0.7-0.80.1-1.7-1.7-1.4-1.8-2.4-2.5-3.5
Number Of Shares End
25.224.923.119.214.614.4119.89.88.77.66.86.6
Net Income Continuing Discontinued Operations
-9.6-14.6-11.6-14.2-130.9-32.7-16.8-14.8-15.7-17.8-14.2-22.8
Normalized Income
-8.8-15.2-11.1-13-13.21.2-18.3-17-15.1-15.4-18.8-16.8-22.6
Interest Income
0.20.20.10.20.20.30.30.40.40.10.100
Interest
4.53.62.62.52.12.221.41.40.70.70.93.1
Net Interest Income
-4.3-3.4-2.5-2.3-1.9-2-1.7-1-1-0.6-0.7-0.9-3
EBIT
-5.2-11.1-9-11.8-10.33.3-30.6-15.4-13.4-15-17.1-13.3-19.7
EBITDA
-4.4-10.2-8.1-10.9-9.54.1-29.8-14.6-12.6-14.2-16.3-12.7-19.1
Reconciled Cost Of Rev.
2.42.12.32.22.43.22.11.82.32.22.82.26.7
Reconciled Depr.
0.80.90.90.90.80.80.80.80.80.80.80.60.6
Profit From Continuing Operations
-9.6-14.6-11.6-14.2-130.9-32.7-16.8-14.8-15.7-17.8-14.2-22.8
Normalized EBITDA
-3.5-10.7-7.6-9.7-9.74.4-11.5-14.8-13-14-17.2-15.3-18.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Accelerate Diagnostics Inc competitor comparison and performance snapshot within industry

Accelerate Diagnostics Inc annual results: revenue, profit, P&L, and margins as of Dec 2024 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue Accelerate Diagnostics Inc Dec-2024 Annual Revenue is $12 Million which is growth of -3.0% YoY.

  • POSITIVE

    Annual Net Profit Accelerate Diagnostics Inc Dec-2024 Annual Net Profit is $-50 Million which is growth of 18.8% YoY.

Accelerate Diagnostics Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
⌄
-0.3%
4.7%
 11.712.112.811.811.29.35.74.20.30.20.1
Cost Of Rev. Ann.
-9.6%
12.9%
999.59.512.26.74.93.21---
Gross Profit Ann.
-
-9.3%
2.72.72.63.3-0.44.54.42.53.2---
Operating Exp. Ann.
-18.9%
-13.2%
383856.666.171.268.277.282.967.466.845.731.6
Operating Profit Ann.
-
-
-35.3-35.3-54-62.8-71.6-63.7-72.8-80.4-64.2-66.5-45.6-31.5
⌄
-
-
-12.4-12.4-6.6-3.2-15.5-14.7-11.5-7.30.90.50.10.1
Other Exp. Ann.
-
-
 -2.4-0.13.59.40.2-0.1-0.5-0.3-0.1-
PBT Ann.
-
-
-50.1-50.1-60.8-62.6-77.7-78.2-84.4-88.1-63.5-66.1-45.5-31.5
Tax Ann.
-
-
-0.1-0.10.9-0.10-0.10.20.50.3--0.5
⌄
-
-
-50-50.1-61.6-62.5-77.7-78.2-84.3-88.3-64-66.4-45.5-30.9
Diluted NI Avail to Com Stockholders Ann.
-
-
-50-50.1-61.6-62.5-77.7-78.2-84.3-88.3-64-66.4-45.5-30.9
EPS Ann.
-
-
 -2.2-4.9-7.6-12.6-14-15.5-16.2-11.8-12.9-10.1-7.1
Diluted EPS Ann.
-
-
 -2.2-4.9-7.6-12.6-14-15.5-16.2-11.8-12.9-10.1-7.1
Number Of Shares End
56.3%
35.6%
 25.214.69.86.65.75.55.45.65.24.64.5
Total Exp. Ann.
-17.4%
-10.6%
 4766.175.683.374.982.18668.466.845.731.6
Net Income Continuing Discontinued Operations Ann.
-
-
-50-50.1-61.6-62.5-77.7-78.2-84.3-88.3-64-66.4-45.5-30.9
Normalized Income Ann.
-
-
-48-50.2-48.6-66.2-84.6-78.4-84.2-88-64-66.3-45.5-30.9
Interest Income Ann.
91.3%
-24.2%
0.70.71.10.60.10.92.82.90.90.50.10.1
Interest Ann.
-5.5%
-1.7%
13.113.17.73.815.515.614.310.1000
EBITDA Ann.
-
-
-33.6-33.6-49.8-55.8-59.6-59.7-67.6-75.4-61.3-63.7-43.7-30.6
Reconciled Cost Of Rev. Ann.
-9.6%
12.9%
999.59.512.26.74.93.21---
Reconciled Depr. Ann.
10.8%
5.5%
3.43.43.332.532.62.62.22.41.80.9
Profit From Continuing Operations Ann.
-
-
-50-50-61.6-62.5-77.7-78.2-84.3-88.3-64-66.4-45.5-30.9
Normalized EBITDA Ann.
-
-
-31.5-33.8-36.6-59.5-69-59.9-67.4-75-61.3-63.7-43.7-30.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-3.3%
2Y CAGR
-4.4%
3Y CAGR
-0.3%
5Y CAGR
4.7%
7Y CAGR
15.8%
10Y CAGR
61%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-32.9%
2Y CAGR
-24.2%
3Y CAGR
-18.9%
5Y CAGR
-13.2%
7Y CAGR
-7.9%
10Y CAGR
1.9%
Operating Expenses Annual Cr is falling faster than historical averages.

Accelerate Diagnostics Inc balance sheet as of Dec 2024: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Accelerate Diagnostics Inc Dec-2024 Total Shareholders Fund is $-56 Million which is growth of -181.8% YoY.

  • NEGATIVE

    Total Assets Accelerate Diagnostics Inc Dec-2024 Total Assets is $29 Million which is growth of -9.0% YoY.

Accelerate Diagnostics Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
⌄
-29.9%
-26.6%
28.631.46583.193.4134.4185.3125.582.9139.369.8
⌄
-10.5%
-9.8%
84.651.387.3118.1156.2141.8127.96.856.33.8
⌄
-
-
-56-19.9-22.3-35.1-62.8-7.457.4118.777.813366
Total Capitalization Ann.
-
-
-9.216.2-5.472.983.1122.7177.5118.777.813366
Tangible Assets Ann.
-
-
-56-19.9-22.3-35.1-62.8-7.457.3118.677.7132.965.8
Working Capital Ann.
-
-
-912.4-10.566.475113.7169.9113.774.4128.864.3
Invested Capital Ann.
-53.6%
-43.1%
7.316.9517383.6122.7177.5118.777.813366
Tangible Book Value Ann.
-
-
-56-19.9-22.3-35.1-62.8-7.457.3118.677.7132.965.8
Borrowings Ann.
-15.7%
-13.1%
66.639.277.5111.1150134.1120.1-00.2
Net Debt Ann.
-10.9%
-6.9%
48.324.738.468.2110.66953.8----
Share Issued Ann.
54.7%
35.6%
25.214.69.86.85.85.55.45.65.25.14.5
Number Of Shares End
56.3%
35.6%
25.214.69.86.65.75.55.45.65.24.64.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-8.9%
2Y CAGR
-33.7%
3Y CAGR
-29.9%
5Y CAGR
-26.6%
7Y CAGR
-19%
10Y CAGR
-8.5%
Total Assets Annual is falling slower than historical averages.
Total Current Liabilities Ann.
1Y CHG
160%
2Y CAGR
-31.6%
3Y CAGR
65.4%
5Y CAGR
30.6%
7Y CAGR
24.3%
10Y CAGR
27.3%
Total Current Liabilities Annual Cr growth is higher than historical averages.

Accelerate Diagnostics Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2024 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Accelerate Diagnostics Inc Book Value Per Share is $-2 which is growth of -28.2% YoY.

  • NEUTRAL

    ROE Accelerate Diagnostics Inc ROE is 0% which is growth of 0% YoY.

Accelerate Diagnostics Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
RoA Ann. %
-
-
-167.03%-127.86%-84.41%-88.06%-68.65%-52.74%-56.84%-61.46%-59.75%-43.51%-54.64%
ROE Ann. %
-
-
------337.25%-100.33%-65.16%-62.96%-45.72%-57.55%
ROIC %
-
-
------13.5-10.6-13.3-19.2-15.2-12.7
OPM Ann. %
-
-
-301.85%-448.03%-492.51%-607.37%-570.53%-783.38%-1,417.44%-1,536.61%-27,032.93%-30,985.71%-25,831.15%
Inventory Turnover Ratio Ann.
19.5%
37%
2.92.21.81.70.80.60.40.1---
Asset Turnover Ann. %
58.7%
32%
0.40.30.20.10.10.100
Working Capital Turnover Ann.
-
-
-1.31-1.20.20.20.100
Quick Ratio Ann.
-60.2%
-46.5%
0.61.30.79.51013.721.716.419.32524
Current Ratio Ann.
-59.6%
-45.8%
0.720.810.611.814.922.917.819.425.324.1
Interest Coverage Ratio Ann.
-
-
-2.8-6.9-15.6-4-4-4.9-7.7--2,873.2-1,977.2-4,493.3
LT Debt To Equity Ann.
-
-
------2.1---
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Current Ratio Ann.
1Y CHG
-65%
2Y CAGR
-6.5%
3Y CAGR
-59.6%
5Y CAGR
-45.8%
7Y CAGR
-37%
10Y CAGR
-29.8%
Current Ratio Annual is falling faster than historical averages.

Accelerate Diagnostics Inc cash flow: net, operating, investing, and financing flows as of Dec 2024 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Accelerate Diagnostics Inc Dec-2024 Cash From Operating Activity is $-24 Million which is growth of 39.8% YoY.

  • POSITIVE

    Net Cash Flow Accelerate Diagnostics Inc Dec-2024 Net Cash Flow is $2 Million which is growth of 110.4% YoY.

Accelerate Diagnostics Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
⌄
-
-
-24.2-40.2-48.7-47.3-50.4-64.8-67.8-55.8-53.4-35.1-18.8
⌄
-
-
-0.58.712.48.313.652.8-20.1-25.7-49.6-2.7-3.4
⌄
-14.4%
31.9%
27.1931.643.211.66.8125.890.41.8104.845.7
Cash Plus Cash Eqv. End Of Year Ann.
-27.7%
-24.4%
15.112.134.939.935.86166.328.519.2120.653.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-17%
-
2.4-22.5-4.74.2-25.2-5.237.99-101.26723.5
Cash Plus Cash Eqv. Begin Of Year Ann.
-30.3%
-28.8%
12.134.939.935.86166.328.519.2120.653.630
Income Tax Paid Supplemental Data Ann.
-
-10.6%
0.4000.7----
Interest Paid Supplemental Data Ann.
-
-
00.12.24.34.34.32----
Capex Ann.
-
-
-0.5-1-0.6-0.6-1.4-0.3-1-3-2.4-3.7-1.9
Issuance Of Capital Stock Ann.
-11.2%
82.1%
30432.942.90.41.50.683.80.2104.244.9
Issuance Of Debt Ann.
21.3%
-43.4%
105.6171.5----
Repayment Of Debt Ann.
-
-
-1.5-1.3-1.3-0.4-0.4---0-0.2-0.1
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-24.7-41.2-49.3-47.9-51.8-65.1-68.8-58.7-55.8-38.8-20.7
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
201.1%
2Y CAGR
-7.4%
3Y CAGR
-14.4%
5Y CAGR
31.9%
7Y CAGR
-15.8%
10Y CAGR
-5.1%
Cash from Financing Annual Activity growth is higher than historical averages.
×